Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Garnero

Showing results (11-20 of 146) with videos related to

Pageof 15
Sort By:
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 23, 1999
Variability and response of urinary resorption markers to hormone replacement therapyP Garnero, P D Delmas
Annales De Biologie Clinique|April 22, 1999
[Biochemical markers of bone turnover : clinical usefulness in osteoporosis]P Garnero, P D Delmas
Bone|February 14, 2003
An immunoassay for type I collagen alpha 1 helicoidal peptide 620-633, a new marker of bone resorption in osteoporosisP Garnero, P D Delmas
The Journal of Clinical Endocrinology and Metabolism|October 1, 1993
Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone diseaseP Garnero, P D Delmas
Endocrinology and Metabolism Clinics of North America|July 21, 1998
Biochemical markers of bone turnover. Applications for osteoporosisP Garnero, P D Delmas
Bone|April 28, 2012
Biological markers in osteoarthritisJ Ch Rousseau, P Garnero
Annals of the Rheumatic Diseases|July 16, 2002
Addition of interleukin 1 (IL1) and IL17 soluble receptors to a tumour necrosis factor alpha soluble receptor more effectively reduces the production of IL6 and macrophage inhibitory protein-3alpha and increases that of collagen in an in vitro model of rheumatoid synoviocyte activationG Chevrel, P Garnero, P Miossec
Clinical and Experimental Rheumatology|February 19, 2004
Biochemical markers of joint tissue turnover in early rheumatoid arthritisP Garnero, P Geusens, R Landewé
Clinical Chemistry|March 29, 2001
Evaluation of a fully automated serum assay for C-terminal cross-linking telopeptide of type I collagen in osteoporosisP Garnero, O Borel, P D Delmas
Rheumatology (Oxford, England)|April 4, 2001
Urinary excretion of glucosyl-galactosyl pyridinoline: a specific biochemical marker of synovium degradationE Gineyts, P Garnero, P D Delmas
Pageof 15

Showing results (11-20 of 146) with videos related to

Sort By:
Pageof 15
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 23, 1999
Variability and response of urinary resorption markers to hormone replacement therapyP Garnero, P D Delmas
Annales De Biologie Clinique|April 22, 1999
[Biochemical markers of bone turnover : clinical usefulness in osteoporosis]P Garnero, P D Delmas
Bone|February 14, 2003
An immunoassay for type I collagen alpha 1 helicoidal peptide 620-633, a new marker of bone resorption in osteoporosisP Garnero, P D Delmas
The Journal of Clinical Endocrinology and Metabolism|October 1, 1993
Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone diseaseP Garnero, P D Delmas
Endocrinology and Metabolism Clinics of North America|July 21, 1998
Biochemical markers of bone turnover. Applications for osteoporosisP Garnero, P D Delmas
Bone|April 28, 2012
Biological markers in osteoarthritisJ Ch Rousseau, P Garnero
Annals of the Rheumatic Diseases|July 16, 2002
Addition of interleukin 1 (IL1) and IL17 soluble receptors to a tumour necrosis factor alpha soluble receptor more effectively reduces the production of IL6 and macrophage inhibitory protein-3alpha and increases that of collagen in an in vitro model of rheumatoid synoviocyte activationG Chevrel, P Garnero, P Miossec
Clinical and Experimental Rheumatology|February 19, 2004
Biochemical markers of joint tissue turnover in early rheumatoid arthritisP Garnero, P Geusens, R Landewé
Clinical Chemistry|March 29, 2001
Evaluation of a fully automated serum assay for C-terminal cross-linking telopeptide of type I collagen in osteoporosisP Garnero, O Borel, P D Delmas
Rheumatology (Oxford, England)|April 4, 2001
Urinary excretion of glucosyl-galactosyl pyridinoline: a specific biochemical marker of synovium degradationE Gineyts, P Garnero, P D Delmas
Pageof 15